Healthy volunteers test new drug combo in early safety trial
Knowledge-focused
Completed
This early-phase study tested two experimental drugs, JLP-2302 and JP-1366, in 55 healthy volunteers to see how the body processes them and if they are safe. Participants were adults with a normal body weight and no major health issues. The goal was to gather basic safety and dru…
Phase: PHASE1 • Sponsor: Onconic Therapeutics Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 03:08 UTC